Literature DB >> 9160854

Contribution of caudal brainstem to d-fenfluramine anorexia.

H J Grill1, J C Donahey, L King, J M Kaplan.   

Abstract

Of the central 5-HT substrates that may mediate the anorexic actions of systemically administered d-fenfluramine (d-FEN), those in the forebrain have received the most attention. As a counterpoint to this forebrain focus, we evaluated the contribution of caudal brainstem substrates to the anorexic action of d-FEN. Two experimental protocols were employed. In one we compared the feeding response (intra-oral intake of 12.5% glucose) of intact and chronic supracollicular decerebrate (CD) rats to systemic administration of d-FEN. In the other, d-FEN was administered via fourth intracerebroventricular (ICV) injection to determine whether a dose-related suppression of intra-oral intake could be obtained. A dose-dependent suppression of intra-oral intake was obtained in the CD rat treated with d-FEN (0-8 mg/kg, delivered IP 20 min before testing). The threshold dose was two to three times higher in CD rats than in their intact controls, but the dynamic range of the dose-response curves of the two groups were overlapping with similar slopes of decline and with comparable maximal intake suppression. Fourth ICV administration of d-FEN in the intact rat yielded a dose-related suppression of intra-oral intake. Intake was also suppressed by fourth ICV d-FEN (30 mg) when rats drank 12.5% glucose solution from a spout. The reduced intra-oral intake following fourth ICV d-FEN treatment was partially attenuated by the systemic administration of the serotonin antagonist metergoline (0.4 mg/kg; IP). The CD results demonstrate the sufficiency of caudal brainstem receptors in mediating intake suppressive responses to systemic d-FEN. The fourth ICV results suggest further that 5-HT receptors in the caudal brainstem play a significant role in normal meal size control in the neurologically intact rat.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160854     DOI: 10.1007/s002130050253

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  6 in total

1.  Chronic hindbrain administration of oxytocin is sufficient to elicit weight loss in diet-induced obese rats.

Authors:  Zachary S Roberts; Tami Wolden-Hanson; Miles E Matsen; Vitaly Ryu; Cheryl H Vaughan; James L Graham; Peter J Havel; Daniel W Chukri; Michael W Schwartz; Gregory J Morton; James E Blevins
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-07-26       Impact factor: 3.619

2.  Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight.

Authors:  H J Grill; A B Ginsberg; R J Seeley; J M Kaplan
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

3.  Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Jean Rivier; Peter Kobelt; Hubert Mönnikes; Nils W G Lambrecht; Yvette Taché
Journal:  Endocrinology       Date:  2009-10-01       Impact factor: 4.736

4.  Serotonin and the regulation of mammalian energy balance.

Authors:  Michael H Donovan; Laurence H Tecott
Journal:  Front Neurosci       Date:  2013-03-27       Impact factor: 4.677

5.  The effect of melanocortin (Mc3 and Mc4) antagonists on serotonin-induced food and water intake of broiler cockerels.

Authors:  Morteza Zendehdel; Farshid Hamidi; Vahab Babapour; Kasra Mokhtarpouriani; Ramin Mazaheri Nezhad Fard
Journal:  J Vet Sci       Date:  2012-09       Impact factor: 1.672

6.  Distribution and neurochemical characterization of neurons within the nucleus of the solitary tract responsive to serotonin agonist-induced hypophagia.

Authors:  Daniel D Lam; Ligang Zhou; Andreas Vegge; Philip Y Xiu; Britt T Christensen; Mayowa A Osundiji; Chen-yu Yueh; Mark L Evans; Lora K Heisler
Journal:  Behav Brain Res       Date:  2008-08-13       Impact factor: 3.332

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.